Savant Capital, LLC Zoetis Inc. Transaction History

Savant Capital, LLC

$11.7 Billion
Q3 2024

A detailed history of Savant Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 5,958 shares of ZTS stock, worth $981,282. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,958

Previous 4,793 24.31%

Holding current value

$981,282

Previous $830,000 40.24%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$172.58 - $196.48 $201,055 - $228,899	1,165 Added 24.31%	5,958 $1.16 Million
Q2 2024 Aug 05, 2024	SELL	$145.54 - $178.83 $186,000 - $228,544	-1,278 Reduced 21.05%	4,793 $830,000
Q1 2024 May 03, 2024	SELL	$165.67 - $199.94 $319,908 - $386,084	-1,931 Reduced 24.13%	6,071 $1.03 Million
Q4 2023 Feb 05, 2024	BUY	$151.44 - $200.09 $99,950 - $132,059	660 Added 8.99%	8,002 $1.58 Million
Q3 2023 Nov 06, 2023	BUY	$167.14 - $192.77 $13,705 - $15,807	82 Added 1.13%	7,342 $1.28 Million
Q2 2023 Aug 04, 2023	BUY	$160.94 - $186.23 $441,941 - $511,387	2,746 Added 60.83%	7,260 $1.25 Million
Q1 2023 May 02, 2023	BUY	$145.48 - $175.02 $89,033 - $107,112	612 Added 15.68%	4,514 $751,000
Q4 2022 Feb 06, 2023	SELL	$131.14 - $157.47 $10,097 - $12,125	-77 Reduced 1.94%	3,902 $571,000
Q3 2022 Oct 28, 2022	SELL	$148.29 - $182.55 $59,316 - $73,020	-400 Reduced 9.13%	3,979 $590,000
Q2 2022 Jul 22, 2022	BUY	$155.97 - $200.09 $191,843 - $246,110	1,230 Added 39.06%	4,379 $753,000
Q1 2022 May 05, 2022	BUY	$181.39 - $234.03 $64,393 - $83,080	355 Added 12.71%	3,149 $595,000
Q4 2021 Feb 08, 2022	BUY	$193.69 - $247.03 $59,269 - $75,591	306 Added 12.3%	2,794 $682,000
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $567 - $629	3 Added 0.12%	2,488 $483,000
Q2 2021 Aug 04, 2021	BUY	$155.9 - $187.99 $4,365 - $5,263	28 Added 1.14%	2,485 $463,000
Q1 2021 May 04, 2021	SELL	$144.0 - $169.39 $14,256 - $16,769	-99 Reduced 3.87%	2,457 $387,000
Q4 2020 Feb 03, 2021	SELL	$157.07 - $174.35 $157 - $174	-1 Reduced 0.04%	2,556 $423,000
Q3 2020 Nov 04, 2020	BUY	$137.1 - $165.37 $10,419 - $12,568	76 Added 3.06%	2,557 $423,000
Q2 2020 Aug 11, 2020	BUY	$111.92 - $142.53 $7,274 - $9,264	65 Added 2.69%	2,481 $340,000
Q1 2020 Apr 30, 2020	BUY	$92.66 - $144.94 $31,967 - $50,004	345 Added 16.66%	2,416 $284,000
Q4 2019 Jan 31, 2020	BUY	$116.25 - $133.25 $15,461 - $17,722	133 Added 6.86%	2,071 $274,000
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $218,160 - $248,897	1,938 New	1,938 $241,000

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Account

Savant Capital, LLC Zoetis Inc. Transaction History